vs
Encompass Health Corp（EHC）与Pediatrix Medical Group, Inc.（MD）财务数据对比。点击上方公司名可切换其他公司
Encompass Health Corp的季度营收约是Pediatrix Medical Group, Inc.的3.1倍（$1.5B vs $493.8M）。Encompass Health Corp净利率更高（9.5% vs 6.8%，领先2.6%）。Encompass Health Corp同比增速更快（9.9% vs -1.7%）。过去两年Encompass Health Corp的营收复合增速更高（8.3% vs -0.1%）
Encompass Health Corp前身为Amcare及HealthSouth，总部位于美国阿拉巴马州伯明翰，是美国规模最大的住院康复服务提供商，在39个州及波多黎各拥有173家住院康复医院，为中风、神经系统疾病、心肺病症、脑损伤等患者提供专业康复诊疗服务。
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
EHC vs MD — 直观对比
营收规模更大
EHC
是对方的3.1倍
$493.8M
营收增速更快
EHC
高出11.6%
-1.7%
净利率更高
EHC
高出2.6%
6.8%
两年增速更快
EHC
近两年复合增速
-0.1%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $493.8M |
| 净利润 | $146.1M | $33.7M |
| 毛利率 | — | — |
| 营业利润率 | 16.7% | 9.9% |
| 净利率 | 9.5% | 6.8% |
| 营收同比 | 9.9% | -1.7% |
| 净利润同比 | 20.8% | 10.5% |
| 每股收益（稀释后） | $1.43 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EHCMD
| Q4 25 | $1.5B | $493.8M | ||
| Q3 25 | $1.5B | $492.9M | ||
| Q2 25 | $1.5B | $468.8M | ||
| Q1 25 | $1.5B | $458.4M | ||
| Q4 24 | $1.4B | $502.4M | ||
| Q3 24 | $1.4B | $511.2M | ||
| Q2 24 | $1.3B | $504.3M | ||
| Q1 24 | $1.3B | $495.1M |
净利润EHCMD
| Q4 25 | $146.1M | $33.7M | ||
| Q3 25 | $126.5M | $71.7M | ||
| Q2 25 | $142.1M | $39.3M | ||
| Q1 25 | $151.5M | $20.7M | ||
| Q4 24 | $120.9M | $30.5M | ||
| Q3 24 | $108.2M | $19.4M | ||
| Q2 24 | $114.1M | $-153.0M | ||
| Q1 24 | $112.5M | $4.0M |
营业利润率EHCMD
| Q4 25 | 16.7% | 9.9% | ||
| Q3 25 | 14.9% | 13.8% | ||
| Q2 25 | 16.2% | 12.8% | ||
| Q1 25 | 16.4% | 7.0% | ||
| Q4 24 | 14.3% | 7.8% | ||
| Q3 24 | 13.6% | 6.6% | ||
| Q2 24 | 14.3% | -31.3% | ||
| Q1 24 | 13.6% | 3.2% |
净利率EHCMD
| Q4 25 | 9.5% | 6.8% | ||
| Q3 25 | 8.6% | 14.5% | ||
| Q2 25 | 9.7% | 8.4% | ||
| Q1 25 | 10.4% | 4.5% | ||
| Q4 24 | 8.6% | 6.1% | ||
| Q3 24 | 8.0% | 3.8% | ||
| Q2 24 | 8.8% | -30.3% | ||
| Q1 24 | 8.5% | 0.8% |
每股收益（稀释后）EHCMD
| Q4 25 | $1.43 | $0.40 | ||
| Q3 25 | $1.24 | $0.84 | ||
| Q2 25 | $1.39 | $0.46 | ||
| Q1 25 | $1.48 | $0.24 | ||
| Q4 24 | $1.18 | $0.37 | ||
| Q3 24 | $1.06 | $0.23 | ||
| Q2 24 | $1.12 | $-1.84 | ||
| Q1 24 | $1.10 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.2M | $375.2M |
| 总债务越低越好 | $2.4B | $570.5M |
| 股东权益账面价值 | $2.4B | $865.9M |
| 总资产 | $7.1B | $2.2B |
| 负债/权益比越低杠杆越低 | 1.00× | 0.66× |
8季度趋势，按日历期对齐
现金及短期投资EHCMD
| Q4 25 | $72.2M | $375.2M | ||
| Q3 25 | $48.7M | $340.1M | ||
| Q2 25 | $99.1M | $224.7M | ||
| Q1 25 | $95.8M | $99.0M | ||
| Q4 24 | $85.4M | $229.9M | ||
| Q3 24 | $147.8M | $103.8M | ||
| Q2 24 | $154.4M | $19.4M | ||
| Q1 24 | $134.4M | $8.0M |
总债务EHCMD
| Q4 25 | $2.4B | $570.5M | ||
| Q3 25 | $2.4B | $577.2M | ||
| Q2 25 | $2.3B | $583.9M | ||
| Q1 25 | $2.3B | $590.5M | ||
| Q4 24 | $2.4B | $597.1M | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.7B | — |
股东权益EHCMD
| Q4 25 | $2.4B | $865.9M | ||
| Q3 25 | $2.4B | $890.7M | ||
| Q2 25 | $2.3B | $833.8M | ||
| Q1 25 | $2.2B | $789.2M | ||
| Q4 24 | $2.1B | $764.9M | ||
| Q3 24 | $2.0B | $732.5M | ||
| Q2 24 | $1.8B | $706.5M | ||
| Q1 24 | $1.7B | $856.2M |
总资产EHCMD
| Q4 25 | $7.1B | $2.2B | ||
| Q3 25 | $6.9B | $2.2B | ||
| Q2 25 | $6.8B | $2.1B | ||
| Q1 25 | $6.6B | $2.0B | ||
| Q4 24 | $6.5B | $2.2B | ||
| Q3 24 | $6.5B | $2.1B | ||
| Q2 24 | $6.4B | $2.0B | ||
| Q1 24 | $6.2B | $2.2B |
负债/权益比EHCMD
| Q4 25 | 1.00× | 0.66× | ||
| Q3 25 | 1.01× | 0.65× | ||
| Q2 25 | 1.02× | 0.70× | ||
| Q1 25 | 1.08× | 0.75× | ||
| Q4 24 | 1.14× | 0.78× | ||
| Q3 24 | 1.20× | — | ||
| Q2 24 | 1.46× | — | ||
| Q1 24 | 1.54× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $346.0M | $114.1M |
| 自由现金流经营现金流 - 资本支出 | $116.7M | — |
| 自由现金流率自由现金流/营收 | 7.6% | — |
| 资本支出强度资本支出/营收 | 14.8% | — |
| 现金转化率经营现金流/净利润 | 2.37× | 3.39× |
| 过去12个月自由现金流最近4个季度 | $439.2M | — |
8季度趋势，按日历期对齐
经营现金流EHCMD
| Q4 25 | $346.0M | $114.1M | ||
| Q3 25 | $270.8M | $137.3M | ||
| Q2 25 | $270.2M | $137.2M | ||
| Q1 25 | $288.6M | $-117.5M | ||
| Q4 24 | $278.8M | $133.0M | ||
| Q3 24 | $267.8M | $91.8M | ||
| Q2 24 | $217.4M | $107.0M | ||
| Q1 24 | $238.8M | $-125.2M |
自由现金流EHCMD
| Q4 25 | $116.7M | — | ||
| Q3 25 | $83.7M | — | ||
| Q2 25 | $113.3M | — | ||
| Q1 25 | $125.5M | — | ||
| Q4 24 | $80.1M | — | ||
| Q3 24 | $120.3M | — | ||
| Q2 24 | $60.5M | — | ||
| Q1 24 | $99.4M | — |
自由现金流率EHCMD
| Q4 25 | 7.6% | — | ||
| Q3 25 | 5.7% | — | ||
| Q2 25 | 7.8% | — | ||
| Q1 25 | 8.6% | — | ||
| Q4 24 | 5.7% | — | ||
| Q3 24 | 8.9% | — | ||
| Q2 24 | 4.6% | — | ||
| Q1 24 | 7.6% | — |
资本支出强度EHCMD
| Q4 25 | 14.8% | — | ||
| Q3 25 | 12.7% | — | ||
| Q2 25 | 10.8% | — | ||
| Q1 25 | 11.2% | — | ||
| Q4 24 | 14.1% | — | ||
| Q3 24 | 10.9% | — | ||
| Q2 24 | 12.1% | — | ||
| Q1 24 | 10.6% | — |
现金转化率EHCMD
| Q4 25 | 2.37× | 3.39× | ||
| Q3 25 | 2.14× | 1.91× | ||
| Q2 25 | 1.90× | 3.49× | ||
| Q1 25 | 1.90× | -5.66× | ||
| Q4 24 | 2.31× | 4.36× | ||
| Q3 24 | 2.48× | 4.72× | ||
| Q2 24 | 1.91× | — | ||
| Q1 24 | 2.12× | -31.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
